127 related articles for article (PubMed ID: 22253220)
1. ID2: A negative transcription factor regulating oligodendroglia differentiation.
Chen XS; Zhang YH; Cai QY; Yao ZX
J Neurosci Res; 2012 May; 90(5):925-32. PubMed ID: 22253220
[TBL] [Abstract][Full Text] [Related]
2. Interactions between ID and OLIG proteins mediate the inhibitory effects of BMP4 on oligodendroglial differentiation.
Samanta J; Kessler JA
Development; 2004 Sep; 131(17):4131-42. PubMed ID: 15280210
[TBL] [Abstract][Full Text] [Related]
3. Could the inhibitor of DNA binding 2 and 4 play a role in white matter injury?
Gou X; Tang Y; Qu Y; Xiao D; Ying J; Mu D
Rev Neurosci; 2019 Jul; 30(6):625-638. PubMed ID: 30738015
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Olig2 during astroglial differentiation in the subventricular zone of a cuprizone-induced demyelination mouse model.
Chen LP; Li ZF; Ping M; Li R; Liu J; Xie XH; Song XJ; Guo L
Neuroscience; 2012 Sep; 221():96-107. PubMed ID: 22771621
[TBL] [Abstract][Full Text] [Related]
5. Developmental changes and subcellular location in inhibitor of DNA binding 2 (Id2) immunoreactivity in the rat Corpus callosum.
Chen XS; Chen XH; Ye JN; Cai QY; Zhan XL; Liu Z; Yao ZX
Acta Histochem; 2012 Nov; 114(7):653-8. PubMed ID: 22172709
[TBL] [Abstract][Full Text] [Related]
6. The mechanistic target of rapamycin pathway downregulates bone morphogenetic protein signaling to promote oligodendrocyte differentiation.
Ornelas IM; Khandker L; Wahl SE; Hashimoto H; Macklin WB; Wood TL
Glia; 2020 Jun; 68(6):1274-1290. PubMed ID: 31904150
[TBL] [Abstract][Full Text] [Related]
7. The complex world of oligodendroglial differentiation inhibitors.
Kremer D; Aktas O; Hartung HP; Küry P
Ann Neurol; 2011 Apr; 69(4):602-18. PubMed ID: 21520230
[TBL] [Abstract][Full Text] [Related]
8. Olig gene function in CNS development and disease.
Ligon KL; Fancy SP; Franklin RJ; Rowitch DH
Glia; 2006 Jul; 54(1):1-10. PubMed ID: 16652341
[TBL] [Abstract][Full Text] [Related]
9. Id2 and Id4 are not the major negative regulators of oligodendrocyte differentiation during early central nervous system development.
Huang H; Wu H; He W; Zhou F; Yu X; Yi M; Du J; Xie B; Qiu M
Glia; 2022 Mar; 70(3):590-601. PubMed ID: 34889481
[TBL] [Abstract][Full Text] [Related]
10. Nuclear expression of S100B in oligodendrocyte progenitor cells correlates with differentiation toward the oligodendroglial lineage and modulates oligodendrocytes maturation.
Deloulme JC; Raponi E; Gentil BJ; Bertacchi N; Marks A; Labourdette G; Baudier J
Mol Cell Neurosci; 2004 Dec; 27(4):453-65. PubMed ID: 15555923
[TBL] [Abstract][Full Text] [Related]
11. Invivo insulin deficiency as a potential etiology for demyelinating disease.
Gong X; Xie Z; Zuo H
Med Hypotheses; 2008 Sep; 71(3):399-403. PubMed ID: 18621485
[TBL] [Abstract][Full Text] [Related]
12. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins.
Lasorella A; Noseda M; Beyna M; Yokota Y; Iavarone A
Nature; 2000 Oct; 407(6804):592-8. PubMed ID: 11034201
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation regulates the expression of the negative transcriptional regulators ID2 and ID4 during OPC differentiation.
Tiane A; Schepers M; Riemens R; Rombaut B; Vandormael P; Somers V; Prickaerts J; Hellings N; van den Hove D; Vanmierlo T
Cell Mol Life Sci; 2021 Oct; 78(19-20):6631-6644. PubMed ID: 34482420
[TBL] [Abstract][Full Text] [Related]
14. Expression of Id2 in the developing limb is associated with zones of active BMP signaling and marks the regions of growth and differentiation of the developing digits.
Lorda-Diez CI; Torre-Pérez N; García-Porrero JA; Hurle JM; Montero JA
Int J Dev Biol; 2009; 53(8-10):1495-502. PubMed ID: 19247943
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of ID protein by growth and differentiation factor 5 (GDF5) through a smad-dependent and MAPK-independent pathway in HUVSMC.
Chen X; Zankl A; Niroomand F; Liu Z; Katus HA; Jahn L; Tiefenbacher C
J Mol Cell Cardiol; 2006 Jul; 41(1):26-33. PubMed ID: 16716349
[TBL] [Abstract][Full Text] [Related]
16. Id2 mediates oligodendrocyte precursor cell maturation arrest and is tumorigenic in a PDGF-rich microenvironment.
Havrda MC; Paolella BR; Ran C; Jering KS; Wray CM; Sullivan JM; Nailor A; Hitoshi Y; Israel MA
Cancer Res; 2014 Mar; 74(6):1822-32. PubMed ID: 24425046
[TBL] [Abstract][Full Text] [Related]
17. Olig1 is downregulated in oligodendrocyte progenitor cell differentiation.
Gong X; Lin T; Sun Z; Fu M; Zuo H; Xie Z
Neuroreport; 2008 Aug; 19(12):1203-7. PubMed ID: 18628665
[TBL] [Abstract][Full Text] [Related]
18. The inhibitor of DNA binding 2 is mainly expressed in oligodendrocyte lineage cells in adult rat brain.
Chen XS; Zhou DS; Yao ZX
Neurosci Lett; 2007 Nov; 428(2-3):93-8. PubMed ID: 18029094
[TBL] [Abstract][Full Text] [Related]
19. Regulation of glioblastoma multiforme stem-like cells by inhibitor of DNA binding proteins and oligodendroglial lineage-associated transcription factors.
Wu Y; Richard JP; Wang SD; Rath P; Laterra J; Xia S
Cancer Sci; 2012 Jun; 103(6):1028-37. PubMed ID: 22380883
[TBL] [Abstract][Full Text] [Related]
20. Sending mixed signals: bone morphogenetic protein in myelination and demyelination.
See JM; Grinspan JB
J Neuropathol Exp Neurol; 2009 Jun; 68(6):595-604. PubMed ID: 19458544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
